TY  - JOUR

T1  - A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase

JO  - Oncotarget

UR  - https://eprints.whiterose.ac.uk/119393/

PY  - 2015/11/22

AU  - Sakurikar N

AU  - Thompson R

AU  - Montano R

AU  - Eastman A

ED  - 

DO  - DOI: 10.18632/oncotarget.6364

VL  - 7

IS  - 2

SP  - 1380

EP  - 1394

Y2  - 2024/12/25

ER  -